Chemours Co
CC · NYSE · United States · Materials · Chemicals
- Coverage
- FY2016–FY2025
- History
- 10 years
- Latest filing
- 10-K · SEC EDGAR
- Reporting
- USD
- Fiscal year end
- December
- Last updated
- Feb 2026
Headline figures
Chemours Co at a glance
In FY2025, Chemours Co reported revenue of USD 5,808 mn, EBITDA of USD 335 mn, EBITDA margin of 5.8%.
| USD mn | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 5,782 | 5,808 | |||
| EBITDA | 727 | 335 | |||
| EBITDA margin | 12.6% | 5.8% | |||
| Free cash flow | -993 | 51 | |||
| ROIC | 4.8% | -0.3% |
The full 10-year history, every line item and each formula are in the platform.
In the platform
- Stat Book — normalized and as-reported IS, BS and CF
- Up to 10 years of annual and quarterly history
- Peer benchmarking and the stock screener
- Corporate risk scorecard
- DCF model from the filed inputs
- Tearsheet and live Excel formulas